Parkinson's disease correlates with promoter methylation in the α-synuclein gene

Movement Disorders

Volumn 30, Issue 4, 2015, Pages 577-580

  Pihlstrøm, Lasse ^a   Berge, Victoria ^a   Rengmark, Aina ^a   Toft, Mathias ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Epigenetics; Methylation; Parkinson's disease; Quantitative trait locus; SNCA

Indexed keywords

ALPHA SYNUCLEIN; MESSENGER RNA; RESTRICTION ENDONUCLEASE;

ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; BRAIN CORTEX; BRAIN TISSUE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATIONAL STUDY; DIGESTION; DISEASE ASSOCIATION; DNA METHYLATION; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN TISSUE; INTRON; PARKINSON DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; ADULT; AGED; FEMALE; GENETIC PREDISPOSITION; GENETICS; MALE; MIDDLE AGED;

ADULT; AGED; ALPHA-SYNUCLEIN; DNA METHYLATION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RNA, MESSENGER;

EID: 84926158758     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.26073     Document Type: Article

References (34)

1. Lill CM, Roehr JT, McQueen MB, et al. Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: the PDGene database. PLoS Genet 2012;8:e1002548.
2. Do CB, Tung JY, Dorfman E, et al. Web-based genome-wide association study identifies two novel loci and a substantial genetic component for Parkinson's disease. PLoS Genet 2011;7:e1002141.
3. International Parkinson's Disease Genomics Consortium (IPDGC) and Wellcome Trust Case Control Consortium 2 (WTCC2). A two-stage meta-analysis identifies several new loci for Parkinson's disease. PLoS Genet 2011;7:e1002142.
4. Nalls MA, Plagnol V, Hernandez DG, et al. Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies. Lancet 2011;377:641-649.
5. Simon-Sanchez J, Schulte C, Bras JM, et al. Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nat Genet 2009;41:1308-1312.
6. Satake W, Nakabayashi Y, Mizuta I, et al. Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease. Nat Genet 2009;41:1303-1307.
7. Hamza TH, Zabetian CP, Tenesa A, et al. Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease. Nat Genet 2010;42:781-785.
8. Pankratz N, Beecham GW, DeStefano AL, et al. Meta-analysis of Parkinson's disease: identification of a novel locus, RIT2. Ann Neurol 2012;71:370-384.
9. Edwards TL, Scott WK, Almonte C, et al. Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease. Ann Hum Genet 2010;74:97-109.
10. Spencer CC, Plagnol V, Strange A, et al. Dissection of the genetics of Parkinson's disease identifies an additional association 5' of SNCA and multiple associated haplotypes at 17q21. Hum Mol Genet 2011;20:345-353.
11. Nalls MA, Pankratz N, Lill CM, et al. Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease. Nat Genet 2014;doi:10.1038/ng.3043.
12. Rhinn H, Qiang L, Yamashita T, et al. Alternative alpha-synuclein transcript usage as a convergent mechanism in Parkinson's disease pathology. Nat Commun 2012;3:1084.
13. Mizuta I, Takafuji K, Ando Y, et al. YY1 binds to alpha-synuclein 3'-flanking region SNP and stimulates antisense noncoding RNA expression. J Hum Genet 2013;58:711-719.
14. Liu Y, Li X, Aryee MJ, et al. GeMes, clusters of DNA methylation under genetic control, can inform genetic and epigenetic analysis of disease. Am J Hum Genet 2014;94:485-495.
15. Matsumoto L, Takuma H, Tamaoka A, et al. CpG demethylation enhances alpha-synuclein expression and affects the pathogenesis of Parkinson's disease. PLoS One 2010;5:e15522.
16. Jowaed A, Schmitt I, Kaut O, Wullner U. Methylation regulates alpha-synuclein expression and is decreased in Parkinson's disease patients' brains. J Neurosci 2010;30:6355-6359.
17. Richter J, Appenzeller S, Ammerpohl O, et al. No evidence for differential methylation of alpha-synuclein in leukocyte DNA of Parkinson's disease patients. Mov Disord 2012;27:590-591.
18. Tan YY, Wu L, Zhao ZB, et al. Methylation of alpha-synuclein and leucine-rich repeat kinase 2 in leukocyte DNA of Parkinson's disease patients. Parkinsonism Relat Disord 2014;20:308-313.
19. Ai SX, Xu Q, Hu YC, et al. Hypomethylation of SNCA in blood of patients with sporadic Parkinson's disease. J Neurol Sci 2014;337:123-128.
20. Song Y, Ding H, Yang J, et al. Pyrosequencing analysis of SNCA methylation levels in leukocytes from Parkinson's disease patients. Neurosci Lett 2014;569:85-88.
21. Pihlstrøm L, Axelsson G, Bjørnara KA, et al. Supportive evidence for 11 loci from genome-wide association studies in Parkinson's disease. Neurobiol Aging 2013;34:1708 e1707-1713.
22. Silver N, Best S, Jiang J, Thein SL. Selection of housekeeping genes for gene expression studies in human reticulocytes using real-time PCR. BMC Mol Biol 2006;7:33.
23. Coulson DT, Brockbank S, Quinn JG, et al. Identification of valid reference genes for the normalization of RT qPCR gene expression data in human brain tissue. BMC Mol Biol 2008;9:46.
24. Lu T, Pan Y, Kao SY, et al. Gene regulation and DNA damage in the ageing human brain. Nature 2004;429:883-891.
25. Jakovcevski M, Akbarian S. Epigenetic mechanisms in neurological disease. Nat Med 2012;18:1194-1204.
26. Weber M, Hellmann I, Stadler MB, et al. Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome. Nat Genet 2007;39:457-466.
27. Raj T, Rothamel K, Mostafavi S, et al. Polarization of the effects of autoimmune and neurodegenerative risk alleles in leukocytes. Science 2014;344:519-523.
28. Gibbs JR, van der Brug MP, Hernandez DG, et al. Abundant quantitative trait loci exist for DNA methylation and gene expression in human brain. PLoS Genet 2010;6:e1000952.
29. Clough RL, Dermentzaki G, Stefanis L. Functional dissection of the alpha-synuclein promoter: transcriptional regulation by ZSCAN21 and ZNF219. J Neurochem 2009;110:1479-1490.
30. Clough RL, Stefanis L. A novel pathway for transcriptional regulation of alpha-synuclein. FASEB J 2007;21:596-607.
31. Xia Y, Saitoh T, Ueda K, et al. Characterization of the human alpha-synuclein gene: genomic structure, transcription start site, promoter region and polymorphisms. J Alzheimers Dis 2001;3:485-494.
32. Scherzer CR, Grass JA, Liao Z, et al. GATA transcription factors directly regulate the Parkinson's disease-linked gene alpha-synuclein. Proc Natl Acad Sci U S A 2008;105:10907-10912.
33. Gerstein MB, Kundaje A, Hariharan M, et al. Architecture of the human regulatory network derived from ENCODE data. Nature 2012;489:91-100.
34. Wang J, Zhuang J, Iyer S, et al. Sequence features and chromatin structure around the genomic regions bound by 119 human transcription factors. Genome Res 2012;22:1798-1812.